XML 34 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2022   47,299,399      
Beginning balance at Dec. 31, 2022 $ 1,736,277,000 $ 5,000 $ 6,136,563,000 $ (4,397,659,000) $ (2,632,000)
Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise or vesting of equity awards (in shares)   2,469,178      
Issuance of common stock upon exercise or vesting of equity awards 555,000   555,000    
Tax withholdings related to net share settlement of equity awards (in shares)   (360)      
Forfeiture of restricted stock (in shares)   $ (1,407)      
Tax withholdings related to net share settlement of equity awards (23,000)   (23,000)    
Settlement of contingent consideration (in shares)   96,198      
Settlement of contingent consideration 8,896,000   8,896,000    
Issuance of common stock for business and asset acquisitions, net of issuance costs (in shares)   119,278      
Issuance of common stock for asset acquisitions 6,820,000   6,820,000    
Issuance of common stock pursuant to public offering, net of issuance costs (in shares)   50,587      
Issuance of common stock in exchange for services 2,500,000   2,500,000    
Stock-based compensation expense 230,880,000   230,880,000    
Other comprehensive income 4,116,000        
Net loss (892,869,000)     (892,869,000)  
Reclassification of foreign currency translation adjustment realized upon sale of foreign subsidiary 0        
Foreign currency translation 4,116,000       4,116,000
Ending balance (in shares) at Dec. 31, 2023   50,032,873      
Ending balance at Dec. 31, 2023 1,097,152,000 $ 5,000 6,386,191,000 (5,290,528,000) 1,484,000
Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise or vesting of equity awards (in shares)   1,783,763      
Issuance of common stock upon exercise or vesting of equity awards 543,000   543,000    
Tax withholdings related to net share settlement of equity awards (4,000)   (4,000)    
Settlement of contingent consideration (in shares)   1,385,532      
Settlement of contingent consideration 14,742,000   14,742,000    
Issuance of common stock for business and asset acquisitions, net of issuance costs (in shares)   802,038      
Issuance of common stock for asset acquisitions 36,801,000   36,801,000    
Issuance of common stock in exchange for services (in shares)   361,579      
Forfeiture of restricted stock 4,799,000   4,799,000    
Stock-based compensation expense 112,344,000   112,344,000    
Other comprehensive income (3,290,000)        
Net loss (547,029,000)     (547,029,000)  
Reclassification of foreign currency translation adjustment realized upon sale of foreign subsidiary 1,492,000       1,492,000
Foreign currency translation $ (4,782,000)       (4,782,000)
Ending balance (in shares) at Dec. 31, 2024 54,365,785 54,365,785      
Ending balance at Dec. 31, 2024 $ 716,058,000 $ 5,000 6,555,416,000 (5,837,557,000) (1,806,000)
Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise or vesting of equity awards (in shares)   1,798,041      
Settlement of contingent consideration 1,237,000   1,237,000    
Issuance of common stock pursuant to public offering, net of issuance costs (in shares)   1,940,550      
Issuance of common stock in exchange for services 18,078,000   18,078,000    
Issuance of common stock in exchange for services (in shares)   102,922      
Forfeiture of restricted stock 777,000 $ 1,000 776,000    
Stock-based compensation expense 81,546,000   81,546,000    
Other comprehensive income 3,657,000       3,657,000
Net loss (312,763,000)     (312,763,000)  
Reclassification of foreign currency translation adjustment realized upon sale of foreign subsidiary $ 0        
Ending balance (in shares) at Dec. 31, 2025 58,207,298 58,207,298      
Ending balance at Dec. 31, 2025 $ 508,590,000 $ 6,000 $ 6,657,053,000 $ (6,150,320,000) $ 1,851,000